Please login to the form below

Not currently logged in
Email:
Password:

Scott Gottlieb

This page shows the latest Scott Gottlieb news and features for those working in and with pharma, biotech and healthcare.

Gottlieb admonishes industry for clinical trial failings

Gottlieb admonishes industry for clinical trial failings

That is according to outgoing FDA commissioner Scott Gottlieb, who says in a statement that there is “a continued reluctance to adopt innovative approaches among sponsors and clinical research organisations.”. ... The information gleaned from these

Latest news

  • NCI head Sharpless named as interim FDA chief NCI head Sharpless named as interim FDA chief

    after Scott Gottlieb departs next month. ... Azar said in a statement that as acting commissioner Sharpless “will be carrying forward Dr Gottlieb’s vision”.

  • FDA chief Scott Gottlieb to step down FDA chief Scott Gottlieb to step down

    Won admiration of industry and public health experts. The FDA’s commissioner Scott Gottlieb has announced he is to leave the post, after less than two years in the role. ... Gottlieb confirmed the news yesterday, after having previously denied rumours

  • Big opportunities in big data, but EMA and industry just getting started Big opportunities in big data, but EMA and industry just getting started

    Europe’s efforts mirror similar announcements from the FDA, where commissioner Scott Gottlieb has unveiled numerous initiatives, including on real world data, integrating health records with clinical trial data, and a

  • GSK’s Advair Diskus faces first generic in US GSK’s Advair Diskus faces first generic in US

    The approval came as the FDA announced new draft guidance that FDA Commissioner Scott Gottlieb said is part of a package of measures that will help accelerate the development of generics,

  • FDA moves into crisis mode as shutdown drags on FDA moves into crisis mode as shutdown drags on

    New drug appraisals already being affected. As the US government shutdown enters a record fourth week, FDA Commissioner Scott Gottlieb says the agency is now facing one of the most significant ... Gottlieb’s list of activities that will have to be

More from news
Approximately 3 fully matching, plus 38 partially matching documents found.

Latest Intelligence

  • Cell and gene therapy Cell and gene therapy

    Interest in cell and gene therapies is undeniable. In January, US FDA Commissioner Scott Gottlieb outlined policies designed to accommodate an anticipated surge in cell and gene therapy submissions. ... Gottlieb highlighted manufacture as a challenge

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics